A randomized, open-label pharmacokinetic trial of tacrolimus extended-release dosing in obese de novo kidney transplant recipients.
Clin Transplant
; 33(8): e13640, 2019 08.
Article
in En
| MEDLINE
| ID: mdl-31206808
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Kidney Transplantation
/
Tacrolimus
/
Graft Rejection
/
Graft Survival
/
Immunosuppressive Agents
/
Kidney Failure, Chronic
/
Obesity
Type of study:
Clinical_trials
/
Etiology_studies
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Transplant
Journal subject:
TRANSPLANTE
Year:
2019
Document type:
Article
Country of publication: